article_metadata: Jiayi Li Xin Zhang Zhuanzhuan Mu Di Sun Yuqing Sun Yansong Lin
article_metadata: 10.3389/fimmu.2022.943916
article_metadata: Front Immunol
article_metadata: 2022 Aug 8;13:943916.
article_metadata: apatinib plus camrelizumab treatment combination immunotherapy differentiated thyroid cancer multitargeted kinase inhibitors plus pd-1/pd-l1 inhibitors therapy radioactive iodine refractory
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/36003403/
article_metadata: Adenocarcinoma / drug therapy Thyroid Neoplasms / drug therapy Thyroid Neoplasms / pathology
article_metadata: Adenocarcinoma / drug therapy Thyroid Neoplasms / drug therapy Thyroid Neoplasms / pathology Case Reports Review Research Support, Non-U.S. Gov't Adult Antibodies, Monoclonal, Humanized Humans Immunotherapy Iodine Radioisotopes / therapeutic use Male Pyridines Antibodies, Monoclonal, Humanized Iodine Radioisotopes Pyridines apatinib camrelizumab
article_metadata: PMC9393697
article_metadata: 36003403
article_metadata: Response to apatinib and camrelizumab combined treatment in a radioiodine refractory differentiated thyroid cancer patient resistant to prior anti-angiogenic therapy: A case report and literature review
article_metadata: 2022